Plasmalogens are a type of phospholipid containing a phosphate group within their molecular structure. Phospholipids are one of the major structural components of cell membranes and are essential biological lipids that physically and chemically support the structure and function of cell membranes. Among phospholipids, plasmalogens are classified as a type of glycerophospholipid, which contains a glycerol backbone.
The glycerol backbone consists of three carbon atoms arranged sequentially. At the third carbon position (③) of the glycerol backbone in plasmalogens, a phosphate group (–PO₄⁻–) is attached, forming the polar head group of the molecule. Through this phosphate group, additional polar head groups such as choline (–CH2–CH2–N⁺(CH3)3) or ethanolamine (–CH2–CH2–NH3+) may be linked. In addition, a fatty acyl group (R2–C(=O)–) is attached to the second carbon position (②) via an ester bond. These structural features are commonly shared with other glycerophospholipids.
In contrast, at the first carbon position (①), a fatty acyl chain is linked not through a typical ester bond but through a vinyl ether linkage (R1–CH=CH–O–). The presence of this vinyl ether linkage is one of the defining structural characteristics of plasmalogens. Because this bond is highly reactive with oxygen, plasmalogens are thought to exhibit antioxidant properties by scavenging reactive oxygen species.
Plasmalogens exist as dozens of molecular species, which arise from different combinations of the fatty chains at the sn-1 and sn-2 positions and the polar head group at the sn-3 position. Differences in these molecular structures are believed to contribute to distinct physiological functions in the body.
Plasmalogens derived from scallops are characterized by a high proportion of molecular species in which the fatty acyl chain at the sn-2 position is derived from docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA). In addition, many of these molecules possess an ethanolamine head group at the sn-3 position, forming ethanolamine plasmalogens.
The vinyl ether linkage at the sn-1 position is chemically unstable and readily oxidized. Because of this property, plasmalogens are thought to react with and scavenge reactive oxygen species (ROS) by undergoing oxidation themselves, thereby protecting other important biological molecules from oxidative damage. Through this mechanism, plasmalogens help protect cell membranes, DNA, lipids, and proteins from damage caused by oxidative stress, thereby supporting the maintenance of normal cellular functions. This antioxidative defense is also thought to contribute to neuronal protection, the prevention of declines in cognitive processing speed, and the reduction of fatigue associated with aging and stress.
Plasmalogens are an important component of the lipid bilayer of cell membranes and play an essential role in regulating membrane flexibility and fluidity. The vinyl ether linkage present in plasmalogens has a lower packing density than conventional ester bonds, creating greater molecular spacing within the membrane structure. As a result, the presence of plasmalogens in cell membranes is thought to increase membrane fluidity. For membrane proteins such as receptors and ion channels to function properly, membrane fluidity must be maintained within an appropriate range. By helping maintain membrane flexibility and fluidity, plasmalogens support the normal function and integrity of neuronal and muscle cells.
Cell membranes contain specialized microdomains known as lipid rafts, where receptors for hormones and neurotransmitters are concentrated. Plasmalogens help stabilize the structure of lipid rafts and maintain appropriate membrane flexibility and fluidity. As a result, the transmission of signals within and between cells, as well as immune responses, can proceed efficiently.
Plasmalogens, through these multiple biological functions, help protect neurons from oxidative stress and contribute to the maintenance of cognitive functions such as memory and concentration. They have also been reported to be associated with a reduced risk of neurodegenerative diseases, including age-related cognitive impairment and Alzheimer’s disease. In addition, potential benefits related to mental well-being and the prevention or alleviation of depressive symptoms have been suggested.
In particular, plasmalogens derived from scallops have been shown to demonstrate superior effects on cognitive function when compared with plasmalogens obtained from other sources.
Scallop-derived plasmalogens may help maintain spatial cognitive function, including the ability to recognize spatial relationships and process positional information. More than 50% of scallop-derived plasmalogens are ethanolamine-type plasmalogens, in which the polar head group at the sn-3 position is ethanolamine. In addition, many molecular species contain docosahexaenoic acid (DHA) at the sn-2 position. This molecular composition resembles that of the predominant plasmalogen species found in the brain. Furthermore, several studies have reported that plasmalogen levels are significantly reduced in the brains of patients with Alzheimer’s disease.
Plasmalogen Levels in the Frontal Cortex and Hippocampus
Source: Guan Z et al. J Neuropathol Exp Neurol. 1999 Jul;58(7):740-7.
HSOP is a food ingredient rich in scallop-derived plasmalogens. Regular intake may help replenish plasmalogens that tend to decline in the brain. In addition, the plasmalogens contained in HSOP are characterized by a molecular composition well suited to supporting the maintenance and improvement of brain function.
Scallop-derived plasmalogens exhibit a wide range of biological functions. In addition to being used as dietary supplements to support health maintenance, they are also being investigated for their potential roles in the prevention and improvement of various diseases. As research continues to progress, their applications are expected to expand further across a broad range of fields.
Based on the results of studies conducted in both animals and humans, the recommended daily intake of HSOP is 0.5–1.0 mg of scallop-derived plasmalogens per day.
| Mutagenicity (Ames test) | Negative |
|---|---|
| Acute toxicity (rat) | LD50＞5,000 mg/kg |
| Repeated-dose toxicity (rat) | NOAEL＞1,000 mg/kg/day |
